A Treat-to-Target Approach in IBD: Contemporary Real-World Perspectives from an International Survey
Journal of Clinical Medicine · 21.01.2025 · 14 (3) · 667
DOI: 10.3390/jcm14030667 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 21.01.2025. Verfasst von Mohmmed Tauseef Sharip und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR Cambridge Biomedical Research Centre.
Abstract (Originalsprache)
Background/Objectives: The management of inflammatory bowel disease (IBD) varies due to differences in healthcare systems, treatment costs, access to diagnostics, and diverse clinical practices between specialists. Despite the frequent advocacy of a treat-to-target (T2T) approach, there is insufficient clarity on how clinicians implement T2T in real-world settings. We aim to conduct a large, global survey among IBD experts to identify current practices in management.
Methods
A prospective, cross-sectional study was conducted using a 16-item survey divided into two sections—for ulcerative colitis (UC) and Crohn’s disease (CD)—and distributed to practicing IBD clinicians.
Results
A total of 261 respondents from 88 countries participated in the survey, with the majority (253/261) being physicians and eight being IBD nurse specialists. Despite global guidance, only a quarter of the respondents routinely perform an endoscopy to assess the response after starting an advanced therapy (28.4% in UC vs. 23.5% in CD). Moreover, despite an increasing academic focus on intestinal ultrasound (IUS), 171 (66%) of respondents in UC and 132 (51%) in CD reported that they do not routinely undertake IUS to guide treatment decisions. Faecal calprotectin for monitoring treatment response was routinely used by 87% (90% in UC and 84% in CD) of the respondents. Forty-five percent reported use of therapeutic drug monitoring (TDM) both proactively and reactively and 35% reported only using TDM reactively.
Conclusions
Our study shows considerable variation in IBD management across different countries and interpretation of the T2T approach. This highlights the need for standardised and pragmatic guidelines to help improve outcomes for patients with IBD globally.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
- Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
ORCID-Profile: Nurulamin M Noor
Förderung
- NIHR Cambridge Biomedical Research Centre
Zitieren
APA
Sharip, M. T., Brezina, B., De La Revilla Negro, J., Subramanian, S., Parkes, M., Raine, T., & Noor, N. M. (2025). A Treat-to-Target Approach in IBD: Contemporary Real-World Perspectives from an International Survey. Journal of Clinical Medicine, 14(3), 667. https://doi.org/10.3390/jcm14030667
Vancouver
Sharip MT, Brezina B, De La Revilla Negro J, Subramanian S, Parkes M, Raine T, et al. A Treat-to-Target Approach in IBD: Contemporary Real-World Perspectives from an International Survey. Journal of Clinical Medicine. 2025;14(3):667. doi:10.3390/jcm14030667
BibTeX
@article{Sharip2025,
author = {Sharip, Mohmmed Tauseef and Brezina, Biljana and De La Revilla Negro, Juan and Subramanian, Sreedhar and Parkes, Miles and Raine, Tim and Noor, Nurulamin M},
title = {A Treat-to-Target Approach in IBD: Contemporary Real-World Perspectives from an International Survey},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {3},
pages = {667},
doi = {10.3390/jcm14030667}
}
EUVIMED